Petros C. Karakousis

7.1k total citations
132 papers, 4.6k citations indexed

About

Petros C. Karakousis is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Petros C. Karakousis has authored 132 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Infectious Diseases, 61 papers in Epidemiology and 38 papers in Molecular Biology. Recurrent topics in Petros C. Karakousis's work include Tuberculosis Research and Epidemiology (85 papers), Mycobacterium research and diagnosis (48 papers) and Infectious Diseases and Tuberculosis (19 papers). Petros C. Karakousis is often cited by papers focused on Tuberculosis Research and Epidemiology (85 papers), Mycobacterium research and diagnosis (48 papers) and Infectious Diseases and Tuberculosis (19 papers). Petros C. Karakousis collaborates with scholars based in United States, India and China. Petros C. Karakousis's co-authors include William R. Bishai, Noton K. Dutta, Michael L. Pinn, Dalin Rifat, J Grosset, Eric L. Nuermberger, Lee G. Klinkenberg, Jong‐Hee Lee, Yu-Min Chuang and Richard E. Chaisson and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Petros C. Karakousis

127 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petros C. Karakousis United States	38	3.1k	2.2k	1.5k	866	586	132	4.6k
Robert N. Husson United States	41	2.7k 0.9×	2.0k 0.9×	2.0k 1.3×	342 0.4×	368 0.6×	85	4.7k
Paul Dolin United Kingdom	17	1.9k 0.6×	1.6k 0.7×	517 0.4×	930 1.1×	350 0.6×	37	3.4k
Olivier Neyrolles France	48	4.1k 1.3×	3.1k 1.4×	2.3k 1.6×	817 0.9×	2.4k 4.1×	131	7.5k
Jordi B. Torrelles United States	39	2.6k 0.8×	2.0k 0.9×	1.3k 0.9×	415 0.5×	1.3k 2.3×	122	4.6k
Christoph Lange Germany	52	6.8k 2.2×	5.7k 2.5×	1.3k 0.9×	2.9k 3.4×	1.4k 2.4×	279	9.8k
Peter M. Keller Switzerland	31	888 0.3×	1.0k 0.5×	1.8k 1.2×	551 0.6×	509 0.9×	146	4.4k
Douglas B. Lowrie United Kingdom	37	3.6k 1.2×	2.9k 1.3×	1.4k 1.0×	958 1.1×	1.9k 3.2×	121	5.6k
Padmini Salgame United States	47	2.9k 1.0×	2.4k 1.1×	1.2k 0.8×	882 1.0×	3.1k 5.2×	142	6.9k
Stefan Ehlers Germany	54	3.7k 1.2×	3.4k 1.5×	2.4k 1.6×	1.1k 1.3×	3.3k 5.7×	146	8.8k
Mahavir Singh Germany	48	1.5k 0.5×	1.3k 0.6×	3.0k 2.1×	477 0.6×	1.8k 3.1×	195	6.3k

Countries citing papers authored by Petros C. Karakousis

Since Specialization

Citations

This map shows the geographic impact of Petros C. Karakousis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petros C. Karakousis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petros C. Karakousis more than expected).

Fields of papers citing papers by Petros C. Karakousis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petros C. Karakousis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petros C. Karakousis. The network helps show where Petros C. Karakousis may publish in the future.

Co-authorship network of co-authors of Petros C. Karakousis

This figure shows the co-authorship network connecting the top 25 collaborators of Petros C. Karakousis. A scholar is included among the top collaborators of Petros C. Karakousis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petros C. Karakousis. Petros C. Karakousis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsieh, Leon L., Elizabeth A. Thompson, Weiqiang Zhou, et al.. (2025). SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19. Science Translational Medicine. 17(799). eadn7527–eadn7527. 1 indexed citations

Chidambaram, Vignesh, Amudha Kumar, Subhi J. Al’Aref, et al.. (2024). COVID-19 in the Initiation and Progression of Atherosclerosis. JACC Advances. 3(8). 101107–101107. 9 indexed citations

Karakousis, Petros C. & Graham Mooney. (2024). Respiratory Isolation for Tuberculosis: A Historical Perspective. The Journal of Infectious Diseases. 231(1). 3–9. 1 indexed citations

Karanika, Styliani, Stefanie Krug, Andrew Garcia, et al.. (2023). The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy. 68(2). e0104323–e0104323. 4 indexed citations

Chidambaram, Vignesh, Amudha Kumar, Marie Gilbert Majella, et al.. (2022). Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 9. 862999–862999. 28 indexed citations

Danchik, Carina, et al.. (2021). Genetic Determinants of Intrinsic Antibiotic Tolerance in Mycobacterium avium. Microbiology Spectrum. 9(2). e0024621–e0024621. 5 indexed citations

Chidambaram, Vignesh, Marie Gilbert Majella, Samuel K. Ayeh, et al.. (2021). Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis. Clinical Infectious Diseases. 73(9). 1580–1588. 23 indexed citations

Danchik, Carina, et al.. (2021). Targeting the Mycobacterium tuberculosis Stringent Response as a Strategy for Shortening Tuberculosis Treatment. Frontiers in Microbiology. 12. 744167–744167. 12 indexed citations

Bruiners, Natalie, Noton K. Dutta, Valentina Guerrini, et al.. (2020). The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis. Journal of Lipid Research. 61(12). 1617–1628. 31 indexed citations

10.

Chidambaram, Vignesh, Akshay Gupte, Jann‐Yuan Wang, Jonathan E. Golub, & Petros C. Karakousis. (2020). The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes. Clinical Infectious Diseases. 73(9). e3409–e3418. 9 indexed citations

11.

Dutta, Noton K., Lee G. Klinkenberg, Gonzalo Colmenarejo, et al.. (2019). Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Science Advances. 5(3). eaav2104–eaav2104. 97 indexed citations

12.

Dutta, Noton K. & Petros C. Karakousis. (2014). PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice. International Journal of Antimicrobial Agents. 44(6). 564–566. 15 indexed citations

13.

Dutta, Noton K., Michael L. Pinn, Ming Zhao, Michelle A. Rudek, & Petros C. Karakousis. (2013). Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis. Journal of Antimicrobial Chemotherapy. 68(6). 1327–1330. 16 indexed citations

14.

Thayil, Seema Madhumal, Ya‐Chi Ho, Robert C. Bollinger, et al.. (2012). Mycobacterium tuberculosis Complex Enhances Susceptibility of CD4 T Cells to HIV through a TLR2-Mediated Pathway. PLoS ONE. 7(7). e41093–e41093. 24 indexed citations

15.

Karakousis, Petros C., Thomas A. Albini, Seema Madhumal Thayil, et al.. (2012). Hypoxia And Increased VEGF Expression In Experimental Ocular Tuberculosis. Investigative Ophthalmology & Visual Science. 53(14). 3650–3650. 1 indexed citations

16.

Ahmad, Zahoor, Mostafa Fraig, Michael L. Pinn, et al.. (2011). Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. Journal of Antimicrobial Chemotherapy. 66(7). 1560–1566. 19 indexed citations

17.

Ahmad, Zahoor, Eric Nuermberger, Rokeya Tasneen, et al.. (2010). Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. Journal of Antimicrobial Chemotherapy. 65(4). 729–734. 42 indexed citations

18.

Karakousis, Petros C., Richard D. Moore, & Richard E. Chaisson. (2004). Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. The Lancet Infectious Diseases. 4(9). 557–565. 149 indexed citations

19.

Karakousis, Petros C., Tetsuyuki Yoshimatsu, Gyanu Lamichhane, et al.. (2004). Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice. The Journal of Experimental Medicine. 200(5). 647–657. 200 indexed citations

20.

Karakousis, Petros C., Sinoj K. John, Enrico Maria Surace, et al.. (2001). Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues.. PubMed. 7. 154–63. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact